You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IMCgp100

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma (Skin), Melanoma, Uveal Trial in Oxford (Tebentafusp)

Recruiting
  • Melanoma (Skin)
  • Melanoma, Uveal
  • Oxford, United Kingdom
    Churchill Hospital, Oxford University Hospitals NHS Trust
Jul 28, 2022

Uveal Melanoma Trial in Worldwide (IMCgp100)

Active, not recruiting
Has Results
  • Uveal Melanoma
  • IMCgp100
  • La Jolla, California
  • +25 more
Mar 10, 2022

Uveal Melanoma Trial in Worldwide (IMCgp100, Dacarbazine, Ipilimumab)

Active, not recruiting
Has Results
  • Uveal Melanoma
  • IMCgp100
  • +3 more
  • Los Angeles, California
  • +55 more
Mar 10, 2022

Malignant Melanoma Trial in New York, Oxford, Glasgow (IMCgp100)

Terminated
Has Results
  • Malignant Melanoma
  • IMCgp100
  • New York, New York
  • +2 more
Jul 1, 2020

Malignant Melanoma Trial in United Kingdom, United States (IMCgp100)

Completed
Has Results
  • Malignant Melanoma
  • IMCgp100
  • Los Angeles, California
  • +8 more
Jul 1, 2020

Uveal Melanoma Trial (Tebentafusp)

Available
  • Uveal Melanoma
  • (no location specified)
Jan 5, 2022

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting
  • Uveal Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 5, 2023

Advanced Melanoma Trial (Tebentafusp, Tebentafusp with Pembrolizumab, Investigators Choice)

Not yet recruiting
  • Advanced Melanoma
  • (no location specified)
Sep 19, 2022

Melanoma, Advanced Disease, Unresectable Trial in Philadelphia (IMCgp100 injection)

Completed
  • Melanoma
  • +2 more
  • IMCgp100 injection
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 11, 2016